SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '1t5o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1E7B_B_HLTB4002_1
(SERUM ALBUMIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 4 ARG A 100
ALA A  55
ALA A 126
GLU A 128
None
1.07A 1e7bB-1t5oA:
undetectable
1e7bB-1t5oA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_B_TRPB81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 8 THR A  87
GLY A  54
ALA A  80
ILE A  58
None
0.81A 1gtnA-1t5oA:
undetectable
1gtnB-1t5oA:
undetectable
1gtnA-1t5oA:
13.33
1gtnB-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_C_TRPC81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 10 ARG A 132
THR A 269
ALA A  47
GLY A 232
THR A 166
None
1.07A 1gtnB-1t5oA:
undetectable
1gtnC-1t5oA:
undetectable
1gtnB-1t5oA:
13.33
1gtnC-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_F_TRPF81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 8 THR A  87
GLY A  54
ALA A  80
ILE A  58
None
0.80A 1gtnE-1t5oA:
undetectable
1gtnF-1t5oA:
undetectable
1gtnE-1t5oA:
13.33
1gtnF-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1GTN_J_TRPJ81_0
(TRP RNA-BINDING
ATTENUATION PROTEIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 8 THR A 269
ALA A  47
GLY A 232
THR A 166
None
0.59A 1gtnI-1t5oA:
undetectable
1gtnJ-1t5oA:
undetectable
1gtnI-1t5oA:
13.33
1gtnJ-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1RG7_A_MTXA161_1
(DIHYDROFOLATE
REDUCTASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 ALA A 156
ASN A 243
THR A 269
ILE A 236
LEU A 320
None
1.13A 1rg7A-1t5oA:
2.1
1rg7A-1t5oA:
17.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_B_TRPB81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 8 GLY A  54
ALA A  80
ILE A  58
THR A  87
None
0.80A 1utdB-1t5oA:
undetectable
1utdC-1t5oA:
undetectable
1utdB-1t5oA:
13.33
1utdC-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1UTD_F_TRPF81_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 8 GLY A  54
ALA A  80
ILE A  58
THR A  87
None
0.81A 1utdF-1t5oA:
undetectable
1utdG-1t5oA:
undetectable
1utdF-1t5oA:
13.33
1utdG-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2A7Q_A_CFBA328_2
(DEOXYCYTIDINE KINASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 4 ILE A  15
ASP A   9
LEU A  12
ARG A 158
None
1.24A 2a7qA-1t5oA:
undetectable
2a7qA-1t5oA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3BOG_C_DVAC10_0
(6.5 KDA GLYCINE-RICH
ANTIFREEZE PROTEIN)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
3 / 3 GLY A 157
GLY A 169
GLY A 165
None
0.40A 3bogC-1t5oA:
undetectable
3bogC-1t5oA:
16.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FRQ_A_ERYA195_1
(REPRESSOR PROTEIN
MPHR(A))
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 ASN A  93
ARG A 132
ASN A 133
ALA A 160
None
1.16A 3frqA-1t5oA:
1.7
3frqA-1t5oA:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FRQ_B_ERYB195_1
(REPRESSOR PROTEIN
MPHR(A))
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 7 ASN A  93
ARG A 132
ASN A 133
ALA A 160
None
1.18A 3frqB-1t5oA:
1.7
3frqB-1t5oA:
19.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3HZN_G_ACTG225_0
(OXYGEN-INSENSITIVE
NAD(P)H
NITROREDUCTASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
3 / 3 PRO A 299
LEU A 300
GLN A 296
None
0.43A 3hznG-1t5oA:
undetectable
3hznH-1t5oA:
undetectable
3hznG-1t5oA:
23.35
3hznH-1t5oA:
23.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M2V_A_BZ1A302_1
(CARBONIC ANHYDRASE 2)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 LEU A 151
VAL A 229
GLY A 218
VAL A 253
THR A 312
None
0.97A 4m2vA-1t5oA:
undetectable
4m2vA-1t5oA:
20.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_C_STRC601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 ILE A 212
ARG A 182
ASP A 227
VAL A 250
None
1.08A 4nkxC-1t5oA:
undetectable
4nkxC-1t5oA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NKX_D_STRD601_2
(STEROID
17-ALPHA-HYDROXYLASE
/17,20 LYASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 ILE A 212
ARG A 182
ASP A 227
VAL A 250
None
1.09A 4nkxD-1t5oA:
undetectable
4nkxD-1t5oA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OKT_A_198A1001_1
(ANDROGEN RECEPTOR)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 LEU A 168
GLY A 165
ARG A  45
MET A 136
ILE A 321
None
1.33A 4oktA-1t5oA:
undetectable
4oktA-1t5oA:
20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEU_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 ARG A 132
THR A 269
ALA A  47
GLY A 232
THR A 166
None
1.03A 5eeuI-1t5oA:
undetectable
5eeuJ-1t5oA:
undetectable
5eeuI-1t5oA:
13.33
5eeuJ-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEV_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 ARG A 132
THR A 269
ALA A  47
GLY A 232
THR A 166
None
1.03A 5eevI-1t5oA:
undetectable
5eevJ-1t5oA:
undetectable
5eevI-1t5oA:
13.33
5eevJ-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5EEW_I_TRPI101_0
(TRANSCRIPTION
ATTENUATION PROTEIN
MTRB)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 ARG A 132
THR A 269
ALA A  47
GLY A 232
THR A 166
None
1.03A 5eewI-1t5oA:
undetectable
5eewJ-1t5oA:
undetectable
5eewI-1t5oA:
13.33
5eewJ-1t5oA:
13.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5GQB_A_GCSA602_1
(CHITINASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
3 / 3 TRP A 272
GLU A 332
ASP A 239
None
0.73A 5gqbA-1t5oA:
2.1
5gqbA-1t5oA:
22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB6_A_ADNA401_1
(ADENOSINE KINASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 GLY A  46
GLN A  17
ALA A  52
ALA A  53
ILE A   6
None
0.80A 5kb6A-1t5oA:
2.1
5kb6A-1t5oA:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KB6_B_ADNB401_1
(ADENOSINE KINASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 GLY A  46
GLN A  17
ALA A  52
ALA A  53
ILE A   6
None
0.82A 5kb6B-1t5oA:
3.3
5kb6B-1t5oA:
21.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KPC_A_SAMA401_0
(PAVINE
N-METHYLTRANSFERASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 12 GLY A  54
GLY A  97
ALA A  85
LEU A  84
ALA A  80
None
0.77A 5kpcA-1t5oA:
4.1
5kpcA-1t5oA:
21.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L94_A_TESA502_1
(CYTOCHROME P450)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 8 VAL A 217
ILE A 212
ALA A 185
THR A 152
VAL A 229
None
1.47A 5l94A-1t5oA:
undetectable
5l94A-1t5oA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L94_A_TESA502_1
(CYTOCHROME P450)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
5 / 8 VAL A 220
ILE A 212
ALA A 185
VAL A 149
VAL A 226
None
0.97A 5l94A-1t5oA:
undetectable
5l94A-1t5oA:
22.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_A_PCFA1808_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 LEU A  77
LYS A  78
ALA A  81
LEU A  84
None
0.70A 5vkqA-1t5oA:
2.3
5vkqD-1t5oA:
2.3
5vkqA-1t5oA:
12.03
5vkqD-1t5oA:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_B_PCFB1805_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 LEU A  77
LYS A  78
ALA A  81
LEU A  84
None
0.70A 5vkqA-1t5oA:
2.3
5vkqB-1t5oA:
2.3
5vkqA-1t5oA:
12.03
5vkqB-1t5oA:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_C_PCFC1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 LEU A  77
LYS A  78
ALA A  81
LEU A  84
None
0.69A 5vkqB-1t5oA:
1.2
5vkqC-1t5oA:
1.2
5vkqB-1t5oA:
12.03
5vkqC-1t5oA:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VKQ_D_PCFD1806_0
(NO MECHANORECEPTOR
POTENTIAL C ISOFORM
L)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
4 / 5 LEU A  77
LYS A  78
ALA A  81
LEU A  84
None
0.70A 5vkqC-1t5oA:
2.3
5vkqD-1t5oA:
2.3
5vkqC-1t5oA:
12.03
5vkqD-1t5oA:
12.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DGX_A_017A101_2
(PROTEASE)
1t5o TRANSLATION
INITIATION FACTOR
EIF2B, SUBUNIT DELTA

(Archaeoglobus
fulgidus)
3 / 3 GLY A 206
ASP A 208
ILE A 181
None
0.62A 6dgxB-1t5oA:
undetectable
6dgxB-1t5oA:
15.02